• Triptolide (PG490): Mechanism and Research Use

  2026-08-17

  Triptolide, also known as PG490, is a transcription-modulating natural product used in cancer research and immunology models. Its reported actions include IL-2 suppression, NF-κB transcriptional inhibition, RNAPII degradation, apoptosis induction, and inhibition of ovarian cancer cell invasion.

• Cl-Amidine: Practical PAD4 Assay Workflows

  2026-08-16

  Cl-Amidine enables direct PAD4 inhibition studies, from enzyme activity assays to histone citrullination and immune-model readouts. This workflow-focused guide covers formulation, controls, disease-model translation, and troubleshooting for cancer research, rheumatoid arthritis research, and septic shock studies.

• AS1842856 Foxo1 Inhibitor: Workflow Guide

  2026-08-15

  Build cleaner metabolic experiments with AS1842856 by separating Foxo1 activity from Foxo1 abundance. This guide connects dose-controlled hepatic assays, autophagy research, and exploratory MSC pathway studies with practical setup, optimization, and troubleshooting advice.

• IDO1 Blockade Activates Tumor-Protective JAK2/STAT3

  2026-08-15

  This study shows that pharmacological inhibition of IDO1 can produce a dual response: stronger immune-cell activation alongside an IL-6-driven, tumor-intrinsic JAK2/STAT3 survival signal. Its single-cell analysis supports combining IDO1 blockade with interventions against the IL-6–JAK2–STAT3 axis rather than treating IDO1 inhibition as an isolated strategy.

• (S)-(+)-Ibuprofen in COX Assays

  2026-08-14

  (S)-(+)-Ibuprofen is a stereochemically defined COX inhibitor for dissecting prostaglandin biology. This guide focuses on how enantiopure material, synthesis quality, assay architecture, and translational interpretation can be integrated into more reliable nonsteroidal anti-inflammatory drug research.

• FDA-Approved Drug Screen Finds MERS-CoV Inhibitors

  2026-08-14

  de Wilde and colleagues used phenotypic screening of an FDA-approved compound library to identify four small molecules that inhibited MERS-CoV replication in cell culture. The study provides a practical repurposing framework for emerging coronavirus research while showing why cell-based activity must be separated from proven clinical efficacy or defined molecular mechanism.

• BMS 309403: From Target to Assay Design

  2026-08-13

  BMS 309403 is a potent, selective FABP4 inhibitor for dissecting lipid-driven inflammation. This article translates recent SERCA2–calcineurin–FoxO1–FABP4 findings into a practical framework for choosing assays, controls, and translational endpoints.

• (+)-Bicuculline: Practical GABAA Workflow

  2026-08-13

  This guide explains how to prepare, store, and quality-control (+)-Bicuculline for controlled studies of GABAergic signaling, synaptic transmission, and related neuronal endpoints. It is a neuroscience research tool only and must not be used for diagnostic, clinical, or therapeutic purposes.

• From pSTAT3 to Proof: Smarter Protein Size Verification

  2026-08-12

  Mechanistic studies of rheumatoid arthritis pain increasingly depend on reliable phosphoprotein measurements. This thought-leadership article connects JAK/STAT biology with assay quality, showing how a Triple color protein ladder can strengthen Western blot interpretation, transfer control, and translational decision-making.

• GKT137831 at the Redox–Ferroptosis Interface

  2026-08-12

  GKT137831 is a dual NADPH oxidase Nox1/Nox4 inhibitor that enables compartment-aware analysis of oxidative stress. This article connects Nox-driven reactive oxygen species with ferroptotic membrane failure and provides assay strategies that separate upstream redox signaling from terminal lipid damage.

• Mouse Neutrophil Cell Isolation Kit: Assay Design

  2026-08-11

  Explore how the Mouse Neutrophil Cell Isolation Kit supports high-purity neutrophil preparation without directly labeling target cells. This guide connects source-specific isolation decisions with emerging CD300LD-targeted mRNA nanovaccine research and practical assay controls.

• Forskolin Workflow for cAMP and HSV-1 Reactivation

  2026-08-10

  Forskolin is a direct adenylate cyclase activator that connects controlled cAMP perturbation with practical models of neuronal latency, stem-cell biology, and hormone release. This workflow emphasizes solvent control, concentration-response design, and phenotype-specific validation rather than treating cAMP elevation as a universal endpoint.

• Calpain Inhibitor I, ALLN: Practical Guide

  2026-08-09

  Calpain Inhibitor I, ALLN (SKU A2602) is a research reagent for probing calpain I/II and selected cathepsin activity in apoptosis, inflammation, and ischemia-reperfusion workflows. It is appropriate for controlled laboratory experiments, but its water insolubility, cysteine-protease profile, and research-use-only status require careful vehicle control, storage, and interpretation.

• EZ Cap Cy5 Firefly Luciferase mRNA Guide

  2026-08-08

  Learn how EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP), SKU R1010, can distinguish mRNA uptake from productive translation in cell viability, proliferation, cytotoxicity, and transfection workflows. This scenario-based guide covers assay design, carrier compatibility, protocol handling, data interpretation, and practical vendor selection.

• Nose-to-Brain Rotigotine Nanoparticles in PD Models

  2026-08-07

  The reference study developed rotigotine-loaded chitosan nanoparticles for intranasal nose-to-brain delivery and evaluated them in SH-SY5Y cells and haloperidol-induced Parkinsonian rats. Its findings link nanoparticle delivery with neuronal uptake, improved tyrosine hydroxylase and alpha-synuclein profiles, behavioral recovery, and selected biochemical indicators of neuroprotection.

456 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page